首页> 外文OA文献 >Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death
【2h】

Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death

机译:小鼠中p53:p44的长寿保证活性改变导致记忆力减退,神经退行性变和过早死亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The longevity-assurance activity of the tumor suppressor p53 depends on the levels of Δ40p53 (p44), a short and naturally occurring isoform of the p53 gene. As such, increased dosage of p44 in the mouse leads to accelerated aging and short lifespan. Here we show that mice homozygous for a transgene encoding p44 (p44+/+) display cognitive decline and synaptic impairment early in life. The synaptic deficits are attributed to hyperactivation of insulin-like growth factor 1 receptor (IGF-1R) signaling and altered metabolism of the microtubule-binding protein tau. In fact, they were rescued by either Igf1r or Mapt haploinsufficiency. When expressing a human or a ‘humanized’ form of the amyloid precursor protein (APP), p44+/+ animals developed a selective degeneration of memory-forming and -retrieving areas of the brain, and died prematurely. Mechanistically, the neurodegeneration was caused by both paraptosis- and autophagy-like cell deaths. These results indicate that altered longevity-assurance activity of p53:p44 causes memory loss and neurodegeneration by affecting IGF-1R signaling. Importantly, Igf1r haploinsufficiency was also able to correct the synaptic deficits of APP695/swe mice, a model of Alzheimer’s disease.
机译:肿瘤抑制因子p53的长寿保证活性取决于Δ40p53(p44)的水平,Δ40p53是p53基因的一种短而天然的同工型。因此,在小鼠中增加p44剂量会导致衰老加速和寿命缩短。在这里,我们显示了编码p44(p44 + / +)的转基因纯合子的小鼠在生命早期显示出认知能力下降和突触损伤。突触缺陷归因于胰岛素样生长因子1受体(IGF-1R)信号的过度激活和微管结合蛋白tau代谢的改变。实际上,它们是由Igf1r或Mapt单倍体功能不全抢救的。当表达人类或“人源化”形式的淀粉样蛋白前体蛋白(APP)时,p44 + / +动物会选择性地变性大脑的记忆形成和获取区域,并过早死亡。从机制上讲,神经退行性病变是由麻痹和自噬样细胞死亡引起的。这些结果表明,改变的p53:p44的长寿确保活性会通过影响IGF-1R信号传导而导致记忆力丧失和神经退行性变。重要的是,Igf1r单倍体功能不足还能够纠正APP695 / swe小鼠(一种阿尔茨海默氏病模型)的突触缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号